Our Product Pipeline
Central lab-based
COVID-19 pandemic has unpresedentedly accelerated and expanded clinical use of molecular diagnostics, which used to be only a small fraction (~10%) of the whole in-vitro diagnostics market. We see a new era with continuously and rapidly growing market share of molecular diagnostics, and we prepare for it with next-generation molecular diagnostic products for central lab use, the backbone of this growing opportunity.
Point-of-care
Technological developments have made more and more miniaturization possible, including liquid handling (e.g. microfluidics), powering (e.g. lithium battery), and sensing (e.g. various biosensors). Therefore, point-of-care diagnostics has been increasingly adopted in our lives. We prepare for such needs with revolutionary products delivering higher performance.
Wearable
Standing in the historic junction witnessing how 5G telecommunication, supercomputing, and cloud-based technologies digitalize our lives, we will soon be armed with all sorts of smart wearable devices taking care of our health and diseases. We prepare for the future with innovative products with inherited deep technologies.
catch our latest move
digital CRISPR assay validated on Clarity digital PCR
Instagram
Copyright © 2022 limitomics - All Rights Reserved.
Powered by GoDaddy
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data. We do not use such data for personalized ads or content.